AdvanSix announced first quarter 2025 financial results with sales up 12% to $378 million, and a significant increase in net income to $23.3 million, compared to a loss in the prior year. This improvement was attributed to better operational performance, continued strength in Plant Nutrients, and a $26 million insurance settlement.
Sales increased by approximately 12% year-over-year, reaching $378 million, driven by a 7% increase in volume and favorable market-based pricing.
Net Income saw a substantial increase of $40.7 million from the prior year, totaling $23.3 million.
Adjusted EBITDA surged by $51.0 million to $51.6 million, with the Adjusted EBITDA Margin improving significantly to 13.7%.
Cash Flow from Operations improved by $47.6 million, reaching $11.4 million, while Free Cash Flow also saw a substantial increase of $49.0 million.
AdvanSix anticipates 2025 to be another dynamic year, but remains well-positioned due to its role as an American manufacturer of essential chemistries, focusing on disciplined cost and cash management while making smart investments for long-term performance.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance